MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.16156

Медицинская библиотека · Anticancer research · 2023

Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.

Goto Wataru, Kashiwagi Shinichiro, Matsuoka Kohei, Iimori Nozomi, Kouhashi Rika, Yabumoto Akimichi, Takada Koji, Asano Yuka, Tauchi Yukie, Ogisawa Kana, Morisaki Tamami, Shibutani Masatsune, Tanaka Hiroaki, Maeda Kiyoshi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIM: Febrile neutropenia (FN) is a potentially life-threatening complication of chemotherapy. In this study, we evaluated the predictors for FN according to neoadjuvant chemotherapy (NAC) in all breast cancer subtypes.

PATIENTS AND

METHODS

We examined 327 patients with breast cancer treated with NAC. The correlation between the development of FN and clinicopathological features, including systemic inflammatory markers, and prognosis was evaluated retrospectively.

RESULTS

There were no significant differences between patients with and without FN in terms of disease-free survival or overall survival (p=0.562, p=0.149, log-rank, respectively). Low body mass index (BMI) (p<0.001), white blood cells (WBC) at baseline (p=0.008), and NAC regimen (p=0.026) significantly related with FN in all patients with breast cancer. Moreover, among patients with hormone receptor-positive/human epidermal growth factor receptor 2-positive breast cancer, low WBC (p=0.007) and low absolute lymphocyte counts (ALC) at baseline (p=0.039) were significantly associated with FN, and overall survival was significantly worse in patients with FN development (p=0.039, log-rank).

CONCLUSION

Poor immune activity-related factors, low ALC or BMI, may be useful to predict the development of FN in patients with breast cancer.

Для цитирования: Goto Wataru, Kashiwagi Shinichiro, Matsuoka Kohei, Iimori Nozomi, Kouhashi Rika, Yabumoto Akimichi, Takada Koji, Asano Yuka, Tauchi Yukie, Ogisawa Kana, Morisaki Tamami, Shibutani Masatsune, Tanaka Hiroaki, Maeda Kiyoshi. Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.. Anticancer research. 2023. DOI: 10.21873/anticanres.16156.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.